ArticleThe Lancet regional health. Western Pacific2025
Ongoing epidemic of scarlet fever in Shanghai and the emergence of M1
Article in The Lancet regional health. Western Pacific, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Temporal trends in pediatric group A streptococcal pharyngitis across the coronavirus disease 2019 era: A large retrospective cohort study.The Journal of international medical research · 2026Article
- Comparing virulence profile of dominantInfectious diseases & immunity · 2026Article
- Epidemiology and clinical characteristics of invasive group A streptococcal infection in the Republic of Korea, 2015-2024: a nationwide multicenter study.The Lancet regional health. Western Pacific · 2026Article
- Emergence of distinct Streptococcus pyogenes emm1 and emm12 lineages in China.Nature microbiology · 2026Article
- Contact Patterns Drive Age-Structured Transmission Dynamics and Seasonality of Scarlet Fever.Pathogens (Basel, Switzerland) · 2026Article
- Evidence for early circulation of the M1UK sublineage of Streptococcus pyogenes in Germany, 2015-2023.Emerging microbes & infections · 2025Article
- Molecular Characterization ofMicroorganisms · 2025Article
- Post-pandemic upsurge of group A streptococcus infections: potential link to impaired herd trained immunity following COVID-19 lockdowns.Frontiers in immunology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The surge of group A Methods: From 2011 to 2024, epidemiological data on notifiable cases of scarlet fever and 3370 GAS isolates from children with scarlet fever were analysed. Incidence rates were calculated as the mean rate per 100,000 population with 95% CIs. Whole genome sequencing was performed on 332 Findings: From 2011 to 2024, a total of 25,539 cases of scarlet fever were reported in Shanghai. The mean incidence declined from 17.1/100,000 population (95%CI 9.7-24.3, pre-COVID-19 period) to 4.8/100,000 population (2.0-10.1, post-COVID-19 period). Children aged 4-9 years represented 85.6% of cases. Sixteen Interpretation: Persistent and periodic predominance of Funding: Shanghai municipal three-year action plan for strengthening the construction of the public health system 2023-2025 (GWVI-2.1.2); Research project of Shanghai Minhang District Health Commission (2024MW45).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.